Overview

Insulin Glulisine, Diabetes Mellitus Type 1

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

To provide local data on efficacy and safety of insulin glulisine in patients with Type 1 Diabetes Mellitus receiving insulin glargine as basic insulin therapy

Phase:

Phase 3

Details

Lead Sponsor:

Sanofi

Treatments:

Insulin
Insulin glulisine
Insulin, Globin Zinc